See more : StarHub Ltd (SRHBY) Income Statement Analysis – Financial Results
Complete financial analysis of Target Group Inc. (CBDY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Target Group Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Amiad Water Systems Ltd. (AMD.TA) Income Statement Analysis – Financial Results
- Bilot Oyj (BILOT.HE) Income Statement Analysis – Financial Results
- KOMEDA Holdings Co., Ltd. (3543.T) Income Statement Analysis – Financial Results
- Healthia Limited (HLA.AX) Income Statement Analysis – Financial Results
- Daan Gene Co., Ltd. (002030.SZ) Income Statement Analysis – Financial Results
Target Group Inc. (CBDY)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.targetgroupinc.ca
About Target Group Inc.
Target Group Inc. cultivates, processes, and distributes curated cannabis products for the adult-use medical and recreational cannabis market in Canada. Its products include cannabis flower and extract pods for vaporizer use, cannabis pre-rolls, k-cup infused coffee and tea pods, infused cannabis beverages and edibles, infused topical products, and CBD wellness products. The company also offers Wisp, a single-use pre-measured pod and vaporizer system for consumers involved in vaporizing natural herbs, including cannabis. It has a collaboration agreement with cGreen, Inc for manufacturing and distributing the patent-pending THC antidote True Focus in the United States, Europe, and the Caribbean; and distribution, collaboration, and licensing agreement with Serious Seeds B.V. The company was formerly known as Chess Supersite Corporation and changed its name to Target Group Inc. in July 2018. The company was incorporated in 2013 and is based in Hamilton, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.72M | 0.00 | 0.00 | 30.00K | 0.00 | 263.00 | 15.43K | 5.92K | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 2.07M | 885.23K | 971.52K | 25.00K | 183.11K | 36.07K | 14.85K | 21.88K | 0.00 | 0.00 | 0.00 |
| Gross Profit | 1.66M | -885.23K | -971.52K | 5.00K | -183.11K | -35.81K | 585.00 | -15.96K | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 44.49% | 0.00% | 0.00% | 16.67% | 0.00% | -13,615.59% | 3.79% | -269.69% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 32.25K | 173.40K | 194.02K | 316.19K | 48.59K | 0.00 |
| General & Administrative | 1.08M | 409.42K | 356.47K | 1.21M | 3.90M | 1.08M | 473.74K | 1.43M | 2.43M | 239.62K | 1.31K |
| Selling & Marketing | 190.89K | 0.00 | 0.00 | 299.00 | 42.05K | 91.85K | 87.31K | 114.04K | 0.00 | 0.00 | 0.00 |
| SG&A | 1.27M | 409.42K | 356.47K | 1.21M | 3.94M | 1.17M | 473.74K | 1.43M | 2.43M | 239.62K | 1.31K |
| Other Expenses | 0.00 | 904.16K | 973.77K | 369.53K | 687.04K | -2.92K | 13.25K | 1.43M | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 1.27M | 1.31M | 1.33M | 1.58M | 4.63M | 1.36M | 660.38K | 1.63M | 2.75M | 288.21K | 1.31K |
| Cost & Expenses | 3.34M | 1.31M | 1.33M | 1.60M | 4.63M | 1.36M | 660.38K | 1.63M | 2.75M | 288.21K | 1.31K |
| Interest Income | 0.00 | 18.03K | 1.04M | 8.07K | 471.53K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 1.44M | 1.12M | 985.63K | 541.73K | 471.53K | 147.06K | 244.37K | 65.01K | 1.54K | 133.00 | 0.00 |
| Depreciation & Amortization | 811.65K | 885.23K | 971.52K | 292.94K | 111.08K | 1.36M | 13.25K | 1.62M | 2.75M | 70.13K | 1.31K |
| EBITDA | 1.95M | -452.79K | -358.72K | -6.24M | -4.72M | -1.36M | -1.63M | -1.62M | -2.75M | -358.34K | 0.00 |
| EBITDA Ratio | 52.38% | 0.00% | 0.00% | -5,128.04% | 0.00% | -515,845.25% | -4,092.89% | -27,394.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | 380.37K | -124.91K | -1.63M | -1.83M | -4.62M | -1.75M | -909.31K | -1.67M | -2.75M | -358.34K | -1.31K |
| Operating Income Ratio | 10.22% | 0.00% | 0.00% | -6,104.52% | 0.00% | -666,647.53% | -5,891.58% | -28,154.39% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -704.04K | -4.07M | 651.05K | -5.50M | -5.68M | -543.67K | -833.38K | -678.49K | -1.54K | 0.00 | 0.00 |
| Income Before Tax | -323.67K | -4.52M | 272.88K | -7.07M | -10.37M | -1.90M | -1.74M | -2.34M | -2.75M | -358.34K | -1.31K |
| Income Before Tax Ratio | -8.70% | 0.00% | 0.00% | -23,579.57% | 0.00% | -722,563.12% | -11,291.19% | -39,619.26% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 3.27M | 743.41K | 300.93K | 479.05K | 396.61K | 853.36K | 613.48K | -2.75M | -133.00 | 0.00 |
| Net Income | -323.67K | -7.79M | -470.53K | -7.37M | -10.85M | -1.90M | -1.74M | -2.34M | -2.75M | -358.34K | -1.31K |
| Net Income Ratio | -8.70% | 0.00% | 0.00% | -24,582.66% | 0.00% | -722,563.12% | -11,291.19% | -39,619.26% | 0.00% | 0.00% | 0.00% |
| EPS | 0.00 | -0.01 | 0.00 | -0.01 | -0.03 | -0.04 | -0.72 | -85.84 | -341.27 | -34.19 | -0.07 |
| EPS Diluted | 0.00 | -0.01 | 0.00 | -0.01 | -0.03 | -0.04 | -0.72 | -85.83 | -341.27 | -34.19 | -0.07 |
| Weighted Avg Shares Out | 617.03M | 617.03M | 595.35M | 566.88M | 410.38M | 46.20M | 2.41M | 27.32K | 8.05K | 10.48K | 20.00K |
| Weighted Avg Shares Out (Dil) | 617.03M | 617.03M | 595.35M | 566.88M | 410.38M | 46.20M | 2.41M | 27.32K | 8.05K | 10.48K | 20.00K |
Source: https://incomestatements.info
Category: Stock Reports